TP53 and skin squamous cell carcinoma: Particularly, the GOF p53 mutant is associated with poor prognosis compared to loss of p53 in skin carcinogenesis [118,119], suggesting GOF mutant p53 proteins as useful therapeutic targets in advanced cSCC.